A federal judge ruled that Elevance Health and four of its executives must face an investor lawsuit. The lawsuit alleges the company recklessly misrepresented the severe financial impact of rising Medicaid costs after pandemic-era enrollment protections were lifted. The ruling highlighted "unusual stock sales" by top executives as a factor strengthening the case.
https://news.bloomberglaw.com/securities-law/elevance-investor-advances-post-pandemic-medicaid-costs-lawsuit